Accordingly, emerging evidence has shown a relevant role of type I DRs (including DRD1 and DRD5) in the regulation of CD4+ T-cell-mediated autoimmune response involved in human individuals undergoing MS and in EAE (Prado et al., 2013). The gene discussed is CD4; the disease is myeloid sarcoma.